Eagle Bluffs Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$515K Buy
3,990
+1,795
+82% +$210K 0.17% 62
2026
Q1
$266K Sell
2,195
-70
-3% -$8.08K 0.1% 73
2025
Q4
$240K Buy
+2,265
New +$213K 0.1% 76
2025
Q2
Sell
-2,318
Closed -$210K 78
2025
Q1
$210K Buy
2,318
+68
+3% +$6.35K 0.11% 74
2024
Q4
$226K Hold
2,250
0.12% 70
2024
Q3
$257K Hold
2,250
0.14% 68
2024
Q2
$280K Sell
2,250
-70
-3% -$9.02K 0.16% 65
2024
Q1
$308K Sell
2,320
-3
-0.1% -$370 0.19% 63
2023
Q4
$255K Buy
2,323
+3
+0.1% +$311 0.17% 63
2023
Q3
$241K Sell
2,320
-53
-2% -$5.71K 0.18% 64
2023
Q2
$276K Buy
2,373
+106
+5% +$12K 0.21% 59
2023
Q1
$243K Buy
2,267
+78
+4% +$8.42K 0.2% 61
2022
Q4
$243K Buy
+2,189
New +$224K 0.25% 59

Other funds holding MRK

Eagle Bluffs Wealth Management's MRK Position: Q2 2026 in Review

Eagle Bluffs Wealth Management increased its Merck (MRK) stake by 82% in Q2 2026, buying an estimated $210K and bringing the position to 3,990 shares worth $515K. The position accounts for 0.17% of the portfolio, ranked #62.

Eagle Bluffs Wealth Management first reported a position in MRK in Q4 2022 and has held it in 13 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Eagle Bluffs Wealth Management held 3,990 shares of Merck worth $515K as of Q2 2026.
  • Eagle Bluffs Wealth Management bought 1,795 Merck shares in Q2 2026, an estimated $210K.
  • Merck made up 0.17% of Eagle Bluffs Wealth Management's portfolio in Q2 2026, its #62 holding.
  • Eagle Bluffs Wealth Management first reported a position in Merck in Q4 2022 and has held it in 13 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Eagle Bluffs Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.